OR WAIT null SECS
This preview of EADV 2026 provides a teaser of new data and interviews being highlighted at this Vienna dermatology conference.
HCPLive will provide on-site coverage of the 2026 European Academy of Dermatology and Venereology (EADV) Congress, held September 30 to October 3 at the Austria Center Vienna, featuring late-breaking trial data and interviews with dermatology leaders.¹,²
The congress returns to Vienna for the third time, following editions in 2007 and 2016, and organizers expect more than 17,000 attendees.³ This year's program includes late-breaking abstracts and poster presentations across prurigo nodularis, alopecia areata, hidradenitis suppurativa, atopic dermatitis, and psoriasis.
Over the course of this 4-day meeting, dermatologists, venereologists, researchers, and other skin health professionals from around the world will convene to review late-breaking clinical trial data, updated guidance, and evolving treatment strategies across the full spectrum of dermatologic disease.
This year's program features late-breaking abstracts, poster presentations, and educational sessions spanning prurigo nodularis, alopecia areata, hidradenitis suppurativa, atopic dermatitis, psoriasis, vitiligo, chronic hand eczema, and the growing role of artificial intelligence (AI) in clinical practice.
HCPLive will be on-site throughout the congress, providing exclusive interviews with dermatology leaders, coverage of notable sessions, and reporting on the latest clinical data shared during the meeting.
Among the many sessions on this year's agenda, the following offer practical updates for clinicians attending the congress.
Wednesday, September 30 • 08:30–10:00 CEST • Hall F2
Overview: Given the diverse skin types dermatologists encounter worldwide, this session will focus on recognizing the distinct presentations of skin disease in patients with skin of color. Speakers will cover nuances in skin of color dermatology, practical management of hidradenitis suppurativa, new developments in vitiligo management, and the varied manifestations of facial pigmentation.
Thursday, October 1 • 10:15–11:45 CEST • Hall A
Overview: This session will bring attendees up to date on the most relevant psoriasis developments, guidelines, and practical knowledge from the past year. Talks will summarize the current understanding of treatment before reviewing recent advances and their impact on clinical practice.
Thursday, October 1 • 10:15–11:45 CEST • Hall F1
Overview: Designed as a focused update, this session will review the latest developments and guidance in chronic hand eczema from the past year. Speakers will outline current disease understanding and discuss how recent treatment advances translate to everyday care.
Thursday, October 1 • 14:15–15:45 CEST • Hall K
Overview: This session will examine clinical variants of atopic dermatitis alongside current treatment recommendations. Attendees will hear a summary of the past year's key developments and guideline updates, followed by a review of recent advances and their implications for practice.
Friday, October 2 • 08:30–10:00 CEST • Hall E1
Overview: As AI tools become more common in clinical settings, this session will review the most relevant recent developments in AI for dermatology. Talks will cover the current state of the field and explore how emerging applications may affect clinical practice.
The HCPLive team will provide ongoing coverage from Vienna, including session highlights, expert interviews, and key clinical takeaways from the EADV Congress 2026.
Editor's note: This summary was created with the help of AI tools.
References
Related Content:
